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Summary
A murine monoclonal antibody, designated 8113, recognizes a cell surface antigen expressed
exclusively on rat T lineage cells. 8113 antibody immunoprecipitated 180-, 120-, and 90-kD
components from rat thymorytes as well as splenic T cells under nonreducing conditions. 8113
antibody specifically inhibited the binding of thymocytes to fibronectin. Furthermore, binding
of rat thymocytes to immobilized synthetic peptide GlyArg-Gly-Asp-Ser-Pro-Cys-BSA was inhibited
by 8113 antibody as was GlyArg-Gly-Asp-Ser-Pro-Cys, but not by Gly-ArgAla-Asp-Ser-Pro-Lys
or Gly-Arg-Gly-Glu-Ser-Pro. Crosslinking of SH3 antigen on double-negative thymocytes and
adult thymocytes, as well as splenic T lymphocytes by 8113 antibody and F(ab')2 fragments of
goat antibodies to mouse immunoglobulin, led to an increase in theconcentration ofcytoplasmic
free Cat+ due to the release of Cat+ from intracellular stores as well as the influx of Ca2+ from
extracellular sources. Expression of interleukin 2 receptor and subsequently cell proliferation was
observed upon incubation of thymocytes and splenic T cells with 8113 antibody. Furthermore,
8113 antibody induced the proliferation of double-negative thymocytes. These data collectively
indicate that a cell surface antigen, 8113, is involved in not only cell adhesion but also involved
in the expression of immature as well as mature thymocytes.
S
ome T cell surface molecules have been shown to be in-
volved in T cell activation and proliferation in human
as well as rodent systems (1-6). The antigen-specific CD3/
TCR molecule complex has been shown to be a major pathway
in T cell activation in humans and mice (1, 2). Recently, two
alternative antigen-independent pathways have been reported
that involve either the SRBC receptor molecule, T11 (CD2)
(3, 4), or the molecule Tp44 (CD28) (5) in humans. In addi-
tion, cell surface molecules that anchored via a specific as-
sociation with phosphatidylinositol have been shown to be
involved in T cell activation (6-8). These are the Thy-1 an-
tigen and the T cell activation antigen TAP. Although the
roll of those antigens in mature T cell activation has been
extensively characterized, less is known about the role of those
antigens in immature thymocyte growth and differentiation.
Furthermore, natural ligands for most of those T cell surface
molecules are not yet identified. Recently, the purified T11
molecules were found to specifically bind to lymphocyte func-
tion-associated antigen 3 (LFA3)r (9) . The detection and
characterization of additional cell surface molecules that are
involved in T cell activationare critical for better understanding
of T cell activation mechanisms. In this context, our present
'Abbreviations used in this paper. HAT, hypoxanthine-aminopterin-thymi-
dine; LFA-3, lymphocyte function-associated antigen 3.
findings ofa novel rat T cell surface molecule, 8113, is clearly
of interest. Antibody directed against this molecule directly
activates immature and mature thymorytes as well as T cells.
The immunochemical nature of this antigen is clearly dis-
tinct from T3, CD2, Tp44, Thy-1, or TAP The 8113 an-
tigen might be involved in the antigen-independent pathway
of T cell activation.
Materials and Methods
Animals.
￿
Inbred 6-8-wk-old male Lewis and Wistar rats, and
BALB/C mice, were purchased from Shizuoka Animal Center
(Hamamatsu, Japan).
Cell Suspensions and Lines.
￿
Single cell suspensions of thymus,
spleen, lymph node, or bone marrow cells ofrat and mouse origin
were prepared as described (10).
Media.
￿
All cell culture studies were performed in Eagle's MEM
(Gibco Laboratories, Grand Island, NY) supplemented with L-glutamine
(2 x 10-3 M), penicillin (100 U/ml), streptomycin (100 lAg/ml),
2-ME (5 x 10-5), and 10% FCS (complete medium).
Production ofmAh
￿
Thymocytes were obtained from 8-wk-old
Lewis rats. BALB/C mice were injected intraperitoneally three times
with 10' thymocytes. 3 d after the last immunization, spleen cells
from the immunized mice were fused with NS/1 myeloma cells
in the presence of polyethylene glycol, according to the method
of K6hler and Milstein (11). After fusion, cells were resuspended
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plete medium at a cell density of 2 x 105 spleen cells and were
seeded in each well of 96-well plates. Cells were kept in HAT
containing complete medium for 2-3 wk until clones appeared.
Thehybridomas obtained were screenedby indirect immunofluores-
cence for the production of antibodies to the rat thymocytes, but
not to B cells, or bone marrow cells of rat origin. 18 clones were
selected forcloningby limiting dilution techniquebecause of anti-
body reactivities to rat thymocytes. Among these 18 clones, one
clone, designated 8H3, was selected andsubjectedto further study.
Antibody subclass determination was by Ouchterlony double im-
munodiffusion with anti-mouse subclass-specific antisera (Miles
Laboratories Inc., Naperville, IL). The 8143 antibody was found
to be IgG1.
Antibodies and Reagents.
￿
Murine mAbs Rl-3B3, R1-10B5, and
RTH-7, which detect rat lymphocyte antigen comparable with
humanCD5, CD8, andCD4, respectively, were used in this study
(12, 13). Therefore, these antibodies were hereafter designated as
anti-CD5,anti-CD8, andanti-CD4,respectively. OX-34 antibody,
which detects rat lymphocyte antigen equivalent to human CD2
(T11), anti-rat CD2, was obtained from Dr.A. F. Williams (Univer-
sity ofOxford)(14). OX-54andOX-55, whichdetect distinct epi-
topes present on the rat CD2 molecule (15), were also provided
by Dr. A. F. Williams. The mAbs R4-8B1 and R1-5111, which
detect rat MHC class I antigen and Thy-1 antigen, respectively,
were also used in this study(16) . R73, whichdetects therat TCR-
a/p structure, was obtained from Dr. Hunig (Wurzburg, FRG)
(17), and anti-rat CD3 antibody was obtained from Dr. Tanaka
(Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)
(18). Anti-rat intercellular adhesion molecule 1 antibody, 1A29,
was supplied by Drs. Tamatani andMiyasaka (Tokyo Metropolitan
Institute of MedicalScience) (19).ART-18 antibody, whichdetects
ratIL2R (p55)was obtained from Drs. H. OsawaandT Diamant-
stein(20). FITC goat anti-rat Ig waspurchasedfrom MeloyLabora-
tories Inc., Springfield, VA, andwasabsorbed with normal ratserum
coupled to Sepharose-211 as described elsewhere (21). FITC goat
anti-rat Ig was also purchased from Meloy Laboratories Inc. R2-
1A6 antibody, which detectsratmacrophages andneutrophils, was
also used in this study (22). Antibodies specific to the conserved
cytoplasmic portionof theintegrin X31 subunitwas obtained from
Dr. R. Hynes(Massachusetts Institute ofTechnology, Cambridge,
MA). This antibody reacts with 0 1 proteins in vertebrate, inver-
tebrate, and fungi (23). Purified rat plasma fibronectin was pur-
chased from Biomedical Technologies, Inc., Cambridge, MA.
Fibronectin-related peptides, Gly-Arg-Gly-Asp-Ser-Pro-Cys, Gly-
Arg-Ala-Asp-Ser-Pro-Lys, andGly-Arg-Gly-Glu-Ser-Pro, were ob-
tained from Peninsula Laboratories, Inc., Belmont, CA. H-Gly-
Arg-Gly-Asp-Ser-Pro-Cys-BSA was obtained from Bachem Fein
Chemikalien AG, Bubendorf, Switzerland. Collagen purified from
rat tail tendon waspurchasedfrom Alfacell Corporation, Bloomfield,
NJ. Vitronectin purified from porcine plasma was purchasedfrom
Wako Pure Chemical Industries, Ltd., Osaka, Japan. Lamininwas
purchased from Collaborative Research, Lexington, MA. Fura-2
pentaacetoxymethylesterwaspurchasedfrom Dcjin, Tokyo, Japan.
Cell Fractionation.
￿
Spleen cells were obtained from Lewis rats,
washed several timesin HBSS (Gibco Laboratories) containing 3%
BSA (B-HBSS), and resuspended at 1.5 x 10'/ml in B-HBSS.
3 ml of thesuspension was added to each Corning 25-cm' plastic
tissue culture flask. Thesewere incubatedfor1 hat room tempera-
ture. After incubation, the nonadherent cells were recovered and
resuspended in HBSS containing 10%FCS.Thenonadherent cells
were further fractionated into a T cell-enriched fraction by using
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a nylon wool column (24). The purity of T cells was >96% as
judged by FACS (FACStar; Becton Dickinson & Co., Sunnyvale,
CA) using anti-CD5 antibody. Double-negativethymocytes were
enriched by thepanningmethod as describedpreviously (25). Briefly,
thymocytes were obtained from day 18 fetuses of Wistar rats.
Thymocytecell suspension wasincubatedwith anti-CD8 and anti-
CD4 antibody for 1 h at 4°C. After washing, cells were loaded
onto F(ab )2fragmentsof goat anti-mouse Ig-coated culture plates.
After a 1-h incubation at 4°C, nonadherent cells were recovered.
This panning procedurewasrepeated twice, and nonadherent cells
were recovered and used as double-negative thymocytes. The pu-
rity of double-negativecellswas >95%a asjudged by FACStaranal-
ysis using anti-CD8 and anti-CD4 antibodies.
Thymocyte BindingAssay.
￿
Thebindingassaywasperformedac-
cording to the method described by Cardarelli and Pierschbacher
(26),with some modification. Briefly, culture dishes (60 x 15 mm)
(3002; Falcon Labware, Oxnard, CA) were coated with theindi-
catedproteins by incubating the protein solutions at various con-
centrations in thedishes overnightat 4°C.Unboundproteins were
removedfrom the dishes by washingwith PBS (150 mM NaCI/10
mM sodium phosphate, pH 7.4). Thedishes were then treatedwith
DME(5 ml perdish)containing BSA(2.5 mg/ml) for2h at 37°C.
Thymocytes were suspended in DME plus BSA (2.5 mg/ml) at
a cell density of 5 x 106/ml, and contaminating nonlymphoid
cells were eliminated by passing the G-10 column twice. Thymo-
cytes were resuspended in the same medium at a cell density of
106/ml. 4ml of thymocyte cell suspension containing 4 x 106 cells
was added to the protein-coated dishes, and the dishes were in-
cubated at 4°Cfor90 min on an orbital shaker at 30 rpm. In some
experiments, the thymocyte binding assay was done in dishes
precoatedwith 10 ug/mlof fibronectin or 200Ag/ml of synthetic
peptide. Unboundcellswere collectedby two gentle washes in PBS,
and the cell number was counted by an automated cell counter
(Coulter Electronics Inc., Hialeah, FL). Attached cells were removed
by treated plates with 0.025% trypsin for 5min at room tempera-
ture with vigorous pipetting according to the method described
by Ignotz and Massague (27). All assays were done in triplicate,
and the data were expressed as the mean ± SEM. According to
this procedure, the sum of unbound and bound cells was almost
equal to the total cell number added to the dishes. Furthermore,
specificity of thymocyte binding to fibronectin was confirmed by
themethod describedby Cardarelli andPierschbacher (26) Accord-
ingly, bound thymocytes to fibronectin-coated dishes were spe-
cificallydetached by adding 1mg/mlGly-Arg-GlyAsp-Ser-Pro pep-
tide for 10 min.
Fluorographic Analysis.
￿
Various lymphoid cells were aliquoted
into volumes containing 106 cells and were pelleted for staining.
Various mAbs were added to the cellsin avolume ofproper dilu-
tion for the mAb and incubatedfor45 minat 4°C. For thedetec-
tion of B cells, various cells were stained with FITC goat anti-rat
Ig for 45 min at 4°C. Cells were washed twice and diluted ap-
propriately forusein theFACStaranalysis. Cellstreatedwith normal
mouse Ig and then with FITC goat anti-mouse Ig were used as
control in FACStaranalysis. In some experiments, cellswere simul-
taneouslystainedwith twoantibodies. First, cells were treatedwith
10 dug/ml of biotinylated anti-CD5 antibody at 4°C for 30 min.
After washing, cells were incubated with an appropriate dilution
ofPE-conjugated avidin (Avidin-PE;Becton DickinsonMonoclonal
Center, Mountain View, CA) at 4°C for 30 min. After washing,
cells were then incubated with FITC-conjugated anti-CD8, anti-
CD4, 8H3, or FITC goat anti-rat Ig. Samples were analyzed by
FACStar. Green fluorescence (515-530-mn wave length) from FITCand redfluorescence (630-nm wave length) from PE were detected
independently and displayed as dot plots or contour map in the
logarithmic scale of fluorescence intensity.
Immunochemical Characterization of 8113-defined Antigen.
￿
Rat
thymocytes or purified rat splenic T cells were also externally la-
beled by I'll by using lactoperoxidase (Sigma Chemical Co., St.
Louis, MO) according to the method described previously (28).
Afteriodination, thecell membraneswere disruptedby adding lysis
buffer (0.05 M Tris HClbuffer, pH 7.4, containing 0.14MNaCl,
0.5% NP-40, 1mM PMSF, 1Ag/mlpepstatin, 0.05% sodium azide,
8 mM iodoacetamide, 0.2 TIU/ml approtinin, and 5 mM EDTA
for 1 h at 4°C and were dialyzed against 0.05 MTris HClbuffer,
pH 7.4, containing 0.1% NP-40at 4°C for 24 h. Aliquots of the
labeledmaterial were then preabsorbed with 1/10 (vol/vol)ofnormal
mouseIg coupledto Sepharose-4B beads. Preabsorbed material was
then incubated with 1/10 (vol/vol) of the 8113 antibody coupled
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to Affi Gelfor4h at room temperature. Thebeadswere then washed
with abuffer containing 0.5 M Tris HCl, pH 7.4, 0.14 M NaCl,
0.1% NP-40 (washing buffer). Afterextensivewashing, thebeads
were extracted with an SDS-PAGE sample buffer (10% SDS, 10%
glycerol, 0.01% bromophenol blue, and 62.5 mM Tris HCl, pH
7.0) for 30 min at room temperature. Then, the SDS-PAGE was
performed underreducing or nonreducing conditions. Proteolytic
peptide mappingof8113 antigenwas carried out according to the
method ofCleaveland et al. (29). The SDS-PAGE was done under
nonreducing condition, and the bands of 180,000, 120,000 and
90,000 were located by alignmentwith autoradiographic exposures
and cut out. The gel slices were then placed in the sample wells
of the second slab's stacking gel. The wells were filled with SDS
sample buffer, and the samples were allowed to equilibrate for 120
min. Protease solution in SDS sample buffer containing 20%
glycerol, 0.05% bromophenol blue, and 0.5 ug of Staphylococcus
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Figure 1.
￿
(a) Cytofluorographic anal-
ysis of rat thymocytes (A), spleen cells
(B), lymph node cells (C), and bone
marrow cells (D) stained with 8113
(14), or normal mouseIg as a control
( r4 ). (b); Two-coloranalysis ofratlym-
phoidcellpopulations. Spleen cells(A,
B, and C), fetal thymocytes obtained
from day 18 fetuses (D), and double-
negative cell-enriched cells (E and F)
were stained with different antibodies.
Antibodies used in each instancearela-
beledon thegraph. Quadrantswere set
with the use of background levels for
FITC-labeled antibody and PE-con-
jugated avidin. Different quadrants (1,
2, 3, and 4) on each panel represent
single-positive green(4)or redfluores-
cent cells(1), ordouble-positive (2)and
double-negative cells(3). Percentage of
positive cellsis marked in each quadrant.
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iaureus V8 protease (Miles Laboratories, Inc.) was laid over the
samples. The gels were further equilibrated for 120 min and elec-
trophoresis was begun. After electrophoresis, the gels were de-
hydrated by using a gel dryer. The radioactivity in the slab gel was
visualized by autoradiography.
Determination of[Cal*]
￿
To load cells with the calcium-specific
Fura-2, cells (101/ml) were incubated at 37°C for 30 min with
1 PM Fura-2 pentaacetoxymethyl ester. The Fura-2-loaded cells were
washed and resuspended in Hepes-buffered 0.9% saline (pH 7.4)
containing 1 MM C2C12, 0.5 mM MgC12, 5 mM KCI, and 1 mM
Na2HP0,. The fluorescence of the cell suspension (10'/ml) was
monitoredwith a fluorescence spectrophotometer (650-1OS; Hitachi,
Japan), and [Ca2+1, was calculated by the method of Grynkiewicz
et al. (30).
Results
Distribution of a Cell Surface Antigen Defined by SH3 Anti-
body. To determine which type of cell expresses the anti-
genic determinant recognizedby SH3, the reactivity of this
antibody with various rat lymphoid cell populations was ex-
amined. Cytofluorographic analysis of rat lymphoid cells
stained with 8H3 antibody is depicted in Fig. 1 a . The results
show that the antigen is present on 96% of thymocytes (A),
54% of spleen cells (B), and 57% of mesenteric lymph node
cells (C), but <1% of bone marrow cells (D). As shown in
Fig. 1 b, two-color analysis of spleen cells clearly demon-
strated that cells bearing SH3 antigen also expresses a T cell
marker such as R1-3B3 (CD5 equivalent) (A). In addition,
cells bearing 8H3 antigen are distinct from B cells (B), as
well as neutrophils and macrophages that are stained by Rl-
1A6 antibody (C). On day 18, fetal thymocytes contained
-10% of double-negative cells (D). Double-negative thymo-
cytes were enriched up to 95% (E) . Those double-negative
thymocytes express 8H3 antigen (F) .
We have also examined the reactivityof 8H3 with various
rat normal tissues by using an immunoperoxidase staining
method. We found that SH3 antibody did not react with
any of the normal tissue tested, such as kidney, brain, liver,
pancreas, and lung.
Biochemical Characterization of 8113-defined Antigen.
￿
The
1251 surface-labeled rat thymorytes and splenic T cells were
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examined, purified by immunoabsorption, and analyzed by
SDS-PAGE. As shown in Fig. 2, the 8H3 antibody immuno-
precipitated 180-, 120-, and 90-kD components under non-
reducing conditions (B) and 120-, and 90-kD components
under reducing conditions (D). 8H3 antigen obtained from
spleen T cells exhibited the same biochemical nature as thymo-
cytes did (data not shown).
To clarify which component of 81,13 antigen is actually
recognized by 8H3 antibody, each component was eluted from
SDS-PAGE gels that were run under nonreducing conditions.
Then, each component was applied to 8H3-coupled Affi Gel,
and immunopurified antigen was re-analyzed by SDS-PAGE.
All three components were affinity purified by 8H3 antibody.
To further characterize the immunochemical nature of these
three bands, proteolytic peptide mapping analysis was per-
formed. As shown in Fig. 3, 180-kD (lane A), 120-kD (lane
B), as well as 90-kD (lane C) bands gave identical peptide
mapping patterns with two major bands being 56 and 40
kD, and two minor bands being 30 and 20 kD.
Binding ofRat Thymocytes to fibronectin Was Inhibited by 8113
Antibody. Rat thymocytes specifically bound to fibronectin,
but not to laminin, collagen type 1, or vitronectin. The binding
of thymorytes was dependent on the concentration of fi-
bronectin. When dishes were precoated with 10 wg/ml of
protein solutions, and 4 x 106 thymocytes were applied to
each dish, bound thymorytes to BSA, fibronectin, laminin,
collagen, and vitronectin were 2 .1 ± 0.2 x 104 (unbound
cell number, 38.8 ± 1.2 x 105), 40.8 ± 1.5 x 104 (34.2
± 0.6 x 105), 2.8 ± 0.5 x 104 (37.9 ± 1.1 x 105), 2.4
± 0.4 x 104 (38.4 ± 1.3 x 105), and 2.1 ± 0.2 x 104
(38 .6 ± 1.5 x 105), respectively.
Data were summarized in Fig. 4. The binding of thymo-
cytes to fibronectin was inhibited by GlyArg-Gly-Asp-Ser-
Pro-Cys, but not by GlyArg-Ala-Asp-Ser-Pro-Lys or Gly-Arg-
Gly-Glu-Ser-Pro (Fig. 4 B). It should be noted that binding
was also inhibited by 8H3 antibody and not by the isotype-
matched control antibody, anti-CD5 antibody. It should be
noted that none of the other antibodies tested (anti-CD4,
CD8, ICAM-1, class I, CD3, CD2, and TCR) failed to in-
hibit the binding of thymorytes to fibronectin (Fig. 4 C) .
Next, we tested whether rat thymocytes bound to an im-
Figure 2.
￿
Immunochemical analysis of 8H3 antigen.
8H3 antigen immunopurified by 8H3 antibody-coupled
(lanes B and D) or isotype-matchedantibody-coupled (lanes
A and C) Affi Gel from thymocyteswas analyzedby SDS-
PAGE under nonreducing (lanes A and B) or reducing
(lanes C and D) conditions. Gels corresponding to 180-
(*), 120- (*) and 90AD ( u ) components were cut,
antigens were eluted, and re-applied to 8H3 antibody-
coupled Affi Gel. Boundfractions were analyzed by SDS-
PAGE under reducing conditions. All threecomponents
were affinity purified by 8H3 antibody as shown in lanes
F (180 kD), G (120 W), and H(90 kD). Lane E represents
the unbound fraction, and is used as a control.mobilized synthetic peptide, Gly-Arg-Gly-Asp-Ser-Pro-Cys-
BSA, and found that thymocytes bound to the synthetic pep-
tide in a dose-dependent manner (data not shown) . The
binding ofrat thymocytes to immobilized synthetic peptide
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Figure 3.
￿
Peptide mapping analysis.
Rat thymocytes were labeled by 1251.
Antigens defined by 8143 antibody
were purified from lysate of 1251-
labeled thymocytes by immunoab-
sorption. Antigens were then ana-
lyzed by SDS-PAGE. Appropriate
bands corresponding to 180 kD (lane
A), 120 kD (lane B), and 90 kD (lane
C) in SDS-PAGE gels were cut out
and digested by enzyme treatment as
described. The digested antigens were
analyzed by SDS-PAGE.
C
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was specifically inhibited by Gly-Arg-Gly-Asp-Ser-Pro-Cys,
but not by Gly-Arg-Ala-Asp-Ser-Pro-Lys or GlyArg-Gly-Glu-
Ser-Pro (Fig. 5 A). Furthermore, this binding was also in-
hibited by 8H3 antibody, but not by isotype-matched con-
trol antibody, anti-CD5, or various mAbs (Fig, 5 B). [Ca2+Ji
are increased in T cells by 8H3 antibody when 8H3 antigen
is crosslinked by F(ab')2 fragments of goat anti-mouse Ig an-
tibody. We examined the possibility that 8H3 antibody might
stimulate [Ca2 +J; in rat thymocytes, splenic T cells, fetal
thymocytes, and double-negative thymocytes as assessed by
an increase in the fluorescence of cells loaded with Fura-2.
By itself, 8H3 antibody was without effect. After cellswere
exposed to 8H3 antibody, however, the addition of F(ab')2
fragments of goat anti-mouse Ig antibody caused a prompt
increase in [Ca2+J; (Fig. 6). When extracellular Ca2+ was
abrogated by the addition of 10 mM EGTA, the increase in
Figure 4.
￿
(A) Binding ofrat thymocytes to fibronectin. Culture dishes (3002; Falcon Labware) (60 x 15 mm) were coated with various concentrations
of fibronectin (O), laminin (*), collagen (*), vitronectin ("), or BSA (sk). 4 x 106 rat thymocytes were applied to each dish and incubated for
90 min at 4°C. Bound cells were counted by a cell counter (Coulter Electronics Inc.). Experiments were done in triplicate, and the data were expressed
as a mean ± SEM. (B and C); Binding experiments were done in the presence of various inhibitors under the same condition as described in A.
Dishes were coated with 10 /tg/ml offibronectin. (B) Thymocytes were added to the plate in the presence or absence ofinhibitors such as Gly-Arg-Gly-
Asp-Ser-Pro-Cys (O), Gly-Arg-Ala-Asp-Ser-Pro-Lys ((]), or Gly-Arg-Gly-Glu-Ser-Pro (/). (C) Thymocytes were added to the plate in the presence
of 8H3 antibody (O), isotype-matched antibody, R1-3133 (0), R73 (0), anti-CD4 (*), anti-CD8 (0), anti-class I (M), antiThy-1 (A), anti-CD3
(*), or anti-ICAM-1 ( * ) antibody. After a 90-min incubation at 4°C, bound cells were counted. All experiments were done in triplicate, and data
were expressed as percent inhibition t SEM.80
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Figure 5.
￿
The inhibition of thymocyte binding to synthetic peptidecon-
taining RGD sequences. Plates were pre-coated with 200 ftg/ml of Arg-
Gly-Asp-Ser-Pro-Cys-BSA overnight at 4°C. After washing, thymocyte
binding to syntheticpeptide-coated plates was determined in the presence
of (A) Gly-Arg-Gly-Asp-Ser-Pro-Cys (O), Gly-Arg-Ala-Asp-Ser-Pro-Lys
(/), or Gly-Arg-Gly-Glu-Ser-Pro (0), or (B) 8H3 antibody (O), isotype-
matched antibody, ("), or various antibodies as indicated in Fig. 4 C.
[Ca2+ ]i in response to crosslinked 8H3 antigen was com-
parable. This result indicates that the increase in [C2211, is
due largely to the release of Ca2+ from intracellular stores.
The increase in [Ca2 +]; could be also induced by an equi-
molar F(ab')2 preparation of 8H3 antibody, crosslinked by
F(ab')2 fragments of goat anti-mouse Ig antibody (data not
shown). No increase in [Ca2+ ]i was observed, with or
without F(ab')2 fragments ofgoat anti-mouse Ig antibody
in response to other mAbs that bind to rat T cells such as
R1-3B3 (CD5 equivalent) or RTH-7 (CD4 equivalent) an-
tibody.
Proliferation ofRat T Lineage Cells Induced by 8H3 Anti-
body. When thymocytes were cultured with immobilized
8H3 antibody, no cell proliferation was observed, whilesplenic
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Crosslinking of 8H3 antigen induces a [Ca2+li response.
Fura-2-loaded thymocytes (A, E, and F), splenic T cells (B), fetal thymo-
cytes of day 18 fetuses (C), or double-negative thymocytes derived from
day 18 fetuses (D) were stimulated by 8H3 antibody (a) and goat anti-mouse
Ig (b), or CD4 antibody (c) in the presence (e) or absence (A, B, C, D,
and F) of 10 mM EGTA.
T cells proliferated considerably under the same condition
(Table 1). Thymocyte proliferation was induced by immobi-
lized 8H3 antibody only when exogenous IIr2 was added
to the culture. Thymocytes do express IIr2R upon stimula-
tion by immobilized 8H3 antibody (data not shown). To de-
termine the functional importance of 8H3 antigen on trig-
gering T cell activation and proliferation, the efficacy of 8H3
antigen in inducing T cell proliferation was compared with
anti-rat TCR antibody R73. In the presence of exogenous
IL-2, R73 induced thymocyte proliferation. However, the in-
tensity of cell proliferation was weak compared with that
induced by 8H3 antibodyplus IIr2. In fetal thymocytes, similar
findings were noted, as 8H3 antibody was a more potentstimulator. Although R73, as well as 8H3, induced splenic
T cell proliferation in the absence of exogenous 11,2, R73
was more efficient than 8H3. Double-negative thymocytes
were enriched up to 95% from day 18 rat fetuses. In contrast
to adult and fetal thymocytes, the proliferation of double-
negative thymocytes was observed upon incubation with im-
mobilized 8H3 antibody alone, whereas R73 alone failed to
stimulate the significant proliferation of double-negative
thymocytes.
Discussion
Various T cell surface antigens were known to be involved
in T cell activation. However, ligands for most of those T
cell molecules are not yet identified. Only LFA-3 was found
as a ligand for CD2 (T11 antigens). We described here that
rat thymocytes specifically bound to fibronectin, as well as
to synthetic fibronectin peptide Gly-Arg-Gly-Ser-Pro-Cys-
BSA. This binding was specifically inhibited by 8H3 anti-
body (although we tested variety of mAbs), as well as Gly-
Arg-Gly-Asp-Ser-Pro-Cys, but not by synthetic peptides in
which one of the essential Arg-GlyAsp sequences was replaced
by Ala or Glu. Therefore, it is likely that 8H3 antigen may
recognize the tripeptides Arg-Gly-Asp present infibronectin.
Functional data strongly suggested the possibility that SH3
antibody recognizes one of the T cell-specific integrin mole-
cules. Furthermore, the SDS-PAGE analysis of 8H3 antigen
exhibited multiunit complexes, revealing the similarity to
chicken integrin complex (31). It was assumed that the 120-
component and 90-kD components represent the ac chain and
(3 chain of integrin, respectively. However, anti-a-1 antisera
failed to react with either of the three components detected
by 8H3 antibody (data not shown). In addition, all three com-
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Adult thymocytes, splenic T cells, and fetal thymocytes obtained from day 18 fetus, or double-negative thymocytes were cultured in 96-well plates
precoated with 50 ug/ml antibody for 2-4 d at a cell density of 2 x 105/well in the presence or absence of 300 pM IL-2.
* Each sample was tested in triplicate. Data were based on three experiments, and values represent mean t SEM.
t Proliferative responses significantly different from medium control (p < 0.01).
ponents eluted from the SDS-PAGE gel rebounded to 8H3
antibody, indicating the possibility that all the bands are
different forms of the one-gene products. To test this possi-
bility, we performed peptide mapping analysis of three com-
ponents and found that the same mapping patterns were ob-
served in all three components. Although data are not shown,
we performed an immunoprecipitation study under different
conditions, since the formation of the a and a chain com-
plex might be disrupted by the inadequate pH or the absence
of Cat+ and Mgt+ (32). Furthermore, we used chemical
crosslinking reagents to study whether 8H3 antigen would
be coprecipitated with other components. However, we could
not detect any associated componentsto 8H3 antigen. Thus,
biochemical aspects of 8H3 antigen clearly suggested that
8H3 antigen is not an integrin. Purification and sequencing
of the NH2-terminal amino acid sequence of SH3 antigen
may clarify the molecular nature of SH3 antigen.
In this report, we determined the role of 8H3 antigen on
the proliferation of early fetal thymocytes, since the distribu-
tion pattern of 8H3 antigen was very similar to that ofCD2
antigen, as opposed to CD3/TCR, whose expression is limited
to a fraction of thymocytes (33). Early fetal thymocytes ex-
press the T11 antigen, which lacks the expression of CD3/
TCR. AntiT112 plus antiT113 stimulation of early thymo-
cytes caused [Ca2 +]i mobilization and increased I1:r2R ex-
pression, and led to thymocyte proliferation ifexogenous IIr2
was provided (34). T cell activationprotein (TAP) is expressed
on 30-40% of double-negative thymocytes and early fetal
thymocytes (8). AntiTAP mAb induces the proliferation of
immature, double-negative thymocytes in the presence of11,2
and PMA. Although Tp44 is also expressed on a subpopu-
lation of thymocytes, the role of the Tp44 molecule in early
Table 1 . Proliferation of T Cells and Thymocytes Induced by 8H3 Antibody
Day Medium 8H3 R73 IL-2 8H3 + IL-2 R73 + IL-2
Thymocyte 2 396 ± 87* 402 ± 93 188 ± 43 1,872 ± 208 12,072 ± 3,725 2,317 ± 128
3 126±48 208±50 118± 65 2,419 ± 284 16,242 ± 3,896 4,988 ± 540
4 91 ± 20 234 ± 80 201 ± 85 1,724 ± 280 14,007 ± 2,459 6,082 ± 437
Splenic T cell 2 1,840 ± 165 4,192 ± 845 4,025 ± 198# 9,572 ± 3,190 ND ND
3 1,832 ± 403 6,278 ± 398# 6,624 ± 508# 18,452 ± 4,118 62,581 ± 3,974 95,982 ± 4,180
4 2,078 ± 516 5,848 ± 510 9,084 ± 443# 24,310 ± 1,188 59,004 ± 4,683 125,431 ± 5,033
Fetal thymocyte 2 2,850 ± 184 3,804 ± 271 2,604 ± 189 9,366 ± 1,742 22,407 ± 4,241 9,538 ± 2,007
3 1,506 ± 96 3,470 ± 304 1,448 ± 107 10,223 ± 1,168 35,427 ± 3,827 12,623 ± 4,103
4 2,432 ± 284 4,011 ± 419 2,607 ± 245 9,210 ± 2,041 31,620 ± 2,714 14,527 ± 3,115
Double-negative 2 2,160 ± 92 6,518 ± 419# 2,034 ± 103 5,842 ± 307 9,842 ± 603 6,042 ± 316
thymocyte 3 1,550 ± 83 5,890 ± 713# 1,845 ± 124 6,256 ± 748 10,965 ± 1,651 6,842 ± 963
4 1,470 ± 175 6,721 ± 506# 1,866 ± 176 64,459 ± 609 10,425 ± 2,172 7,267 ± 1,032thymocyte activation andproliferation is not well understood.
A new murine T cell-activating molecule, thymocyte-activa-
ting molecule (THAM), has been recently described (35).
THAM was found to consist of two polypeptides, 110 and
128 kD under nonreducing conditions. Crosslinking of
THAM . induced the proliferation of both double-negative
and mature thymocytes in the presence of either PMA or
IL1 and IL2. Furthermore, TCRmediated proliferation was
prominent in peripheral T cells. However, the significant
proliferation of fetal as well as double-negative thymocytes
was not observed by R73 stimulation under the condition
we used. In contrast to these observations, rat double-negative
thymocytes exhibited a proliferative response upon treatment
with immobilized 8113 antibody, even in the absence of ex-
ogenous 11,2. The proliferation detected with double-negative
thymocytes was not due to the contamination of mature
thymocytes, because adult and fetal thymocytes did not show
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